Analytical Data
-
Gene name
FGF17
- Application
-
Alternative Names
FGF17;Fibroblast growth factor 17
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60258
-
Expression Region
23-216aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMTQGEN HPSPNFNQYV RDQGAMTDQL SRRQIREYQL YSRTSGKHVQ VTGRRISATA EDGNKFAKLI VETDTFGSRV RIKGAESEKY ICMNKRGKLI GKPSGKSKDC VFTEIVLENN YTAFQNARHE GWFMAFTRQG RPRQASRSRQ NQREAHFIKR LYQGQLPFPN HAEKQKQFEF VGSAPTRRTK RTRRPQPLT
-
Molecular Weight
25 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor 17 (FGF17) is a member of the fibroblast growth factor (FGF) family, which plays a critical role in various physiological processes, including embryonic development, tissue repair, and homeostasis. FGF17 is particularly significant in the development of the central nervous system, where it influences neuronal survival, differentiation, and patterning. Recent studies have highlighted its potential involvement in neurological disorders and other conditions, making it a target of interest for therapeutic applications. The ability to produce recombinant FGF17 protein offers valuable opportunities for researchers to investigate its biological functions and mechanisms of action in a controlled environment. By utilizing recombinant technology, scientists can obtain substantial quantities of purified FGF17, facilitating in vitro and in vivo studies. Furthermore, understanding the signaling pathways and interactions mediated by FGF17 may provide insights into its role in health and disease, paving the way for the development of novel interventions. Overall, the study of recombinant FGF17 holds promise for advancing our knowledge of growth factor biology and its implications in regenerative medicine.
